Background Increasing attention has been dedicated to investigate modifiable risk factors of
late effects in survivors of childhood cancer. This study aims to evaluate neurocognitive and …

Background Childhood cancer survivors are at increased risk of late mortality (death≥ 5
years after diagnosis) from cancer recurrence and treatment‐related late effects. The authors …

Late mortality of European 5‐year survivors of childhood or adolescent cancer has dropped
over the last 60 years, but excess mortality persists. There is little information concerning …

Abstract Background Survivors of Hodgkin lymphoma (HL) are at risk of developing non‐
Hodgkin lymphoma (NHL) after treatment; however, the risks of developing subsequent …

Background As survivors of childhood cancer age, development of cancer treatment-related
chronic health conditions often occur. This study aimed to describe the pattern of chronic …

PURPOSE Blood or marrow transplantation (BMT) is an integral part of consolidation and/or
salvage therapy for patients with acute myeloid leukemia (AML). With the growing …

Background Despite progress in managing cancer in children, adolescents, and young
adults (CAYAs), persistent complications may impact their quality of life. This study covers …

Introduction Venous thromboembolism (VTE), a common complication in cancer patients,
occurs more often during the initial phase of treatment. However, information on VTE beyond …

Purpose: Childhood, adolescent, and young adult (CAYA) cancer survivors (age 0–39 years
at diagnosis) are at increased risk of cardiovascular disease (CVD). Family history of early …

Objective Investigate all‐cause and cause‐specific late mortality after childhood acute
lymphoblastic leukemia (ALL) in a population‐based Nordic cohort. Methods From the …